Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 98 | 120 | 168 | 366 | 214 |
| Cost of Goods | 11 | 107 | 14 | 831 | 1,170 |
| Gross Profit | 87 | 13 | 154 | -465 | -956 |
| Operating Expenses | 14,326 | 15,972 | 10,267 | 10,859 | 14,507 |
| Operating Income | -14,228 | -15,852 | -10,099 | -10,493 | -15,293 |
| Interest Expense | 4,373 | 4,222 | 3,993 | 4,032 | 3,790 |
| Other Income | -12,310 | 887 | 6,838 | 3,666 | 5,433 |
| Pre-tax Income | -30,911 | -19,187 | -7,254 | -10,859 | -13,650 |
| Net Income Continuous | -30,911 | -19,187 | -7,254 | -10,859 | -13,650 |
| Net Income | $-30,911 | $-19,187 | $-7,254 | $-10,859 | $-13,650 |
| EPS Basic Total Ops | -2.18 | -2.45 | -1.50 | -1.17 | -5.15 |
| EPS Basic Continuous Ops | -2.18 | -2.45 | -1.50 | -1.17 | -5.15 |
| EPS Diluted Total Ops | -2.18 | -2.45 | -1.50 | -1.17 | -5.15 |
| EPS Diluted Continuous Ops | -2.18 | -2.45 | -1.50 | -1.17 | -5.15 |
| EPS Diluted Before Non-Recurring Items | -2.18 | -2.45 | -1.50 | -3.57 | -5.12 |
| EBITDA(a) | $-14,153 | $-15,777 | $-10,023 | $-10,416 | $-15,216 |